Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT04452500 · VA Office of Research and Development

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

(SEVEN)

What this study is about

The purpose of this study is to test the drug CORT108297, which blocks the hormone cortisol, for treatment of PTSD in Veterans, and establish a safety profile that will inform the design of future studies.

View original scientific description

The purpose of this study is to test the drug CORT108297, which blocks the hormone cortisol, for treatment of PTSD in Veterans, and establish a safety profile that will inform the design of future studies.

Interventions

DRUG

CORT108297

CORT108297- 180mg daily for 7 days

DRUG

Placebo

Placebo- 180mg daily for 7 days

Primary outcome measures

Clinician Administered PTSD Scale for DSM-5 (CAPS)

Time frame: 56 days

The CAPS is a 30-item interview that is the gold standard assessment for PTSD. The CAPS provides a dimensional and categorical measure of PTSD, and incorporates frequency and intensity of symptoms into a single severity score.

Frequency, Intensity, Burden of Side Effects (FIBSER)

Time frame: 56 days

The FIBSER is a self-report 0-6 Likert-type scale that measures global frequency, intensity, and overall burden of side effects.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • History of US military service
  • Capable of reading and understanding English
  • Able to provide written informed consent
  • Symptoms of PTSD (must score 23 or greater on the CAPS-5 assessment at screening visit)
  • Men and pre-menopausal women must agree to use two forms of reliable contraception, one of which is a barrier method.
  • Participants who use an SSRI or SNRI medication for PTSD must be on a stable dose for 8 weeks before enrollment.
  • Participants who use trazodone for sleep must be on a stable dose.
  • Participants who use opiate pain medication must be on a stable dose.
  • For participants who are in psychotherapy, treatment must be stable for 6 weeks.

Exclusion criteria

  • Alcohol use that meets criteria for Alcohol Use Disorder in past 3 months.
  • Marijuana or other drug use that meets criteria for Substance Use Disorder in past 3 months.
  • Ever diagnosed with: Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Obsessive-Compulsive Disorder,

Where

  • Tuscaloosa, Alabama
  • San Francisco, California

Related conditions & keywords

PTSDGlucocorticoidsPosttraumatic Stress DisorderQuality of Life

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jan 29, 2026 · Source of record for eligibility and locations

📊
1 of 40 participants interested
3% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Tuscaloosa

Alabama

Location available
RECRUITING

San Francisco

California

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More PTSD Trials by City

Browse all ptsd clinical trials in these cities — not just this study.

Browse More Trials by Condition

Looking for PTSD Treatment in Tuscaloosa?

Join others in Alabama exploring innovative treatment options through clinical research

PTSD Treatment Options in Tuscaloosa, Alabama

If you're searching for PTSD treatment in Tuscaloosa, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Tuscaloosa, San Francisco and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with PTSD. All study-related care is provided at no cost to participants.

Local Sites
2 locations in Alabama
Now Enrolling
Up to 40 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for PTSD?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for PTSD

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This PTSD Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT04452500. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.